International trends in incidence of osteosarcoma (1988-2012).
bone cancer
epidemiology
incidence
international
osteosarcoma
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
revised:
30
04
2021
received:
17
12
2020
accepted:
03
05
2021
pubmed:
9
5
2021
medline:
7
9
2021
entrez:
8
5
2021
Statut:
ppublish
Résumé
Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. The etiology of OS is largely unknown but may be informed by comparisons of incidence and trends between geographic regions. Using the Cancer Incidence in Five Continents (CI5) data from 1988 to 2012, we present OS age-standardized incidence rates (ASRs; cases/million) and average annual percent change (AAPC) and 95% confidence interval (CI) by geographic region among the age groups 0-9, 10-19, 20-29, 30-59, 60-79, 0-79. Among the 10-19 age group, we also used the most recent data (2008-2012) to present the ASRs for each country. We observed little variation in OS incidence between geographic regions in 2008-2012 across all age groups. Overall, the ASR for 0-79 ranged from 2 cases per million in Southern Asia to 4.2 in Sub-Saharan Africa. A bimodal distribution in incidence was observed with peaks in the 10-19 and 60-79 age groups across all regions over time. Overall, OS incidence was relatively stable across 1988-2012 with the only statistically significant increases in the 0-79 age group observed in Eastern Asia (AAPC: 1.8; 95% CI: 0.6, 1.9) and Sub-Saharan Africa (AAPC: 3.1; 95% CI: 0.5, 5.8). The small variation in incidence between regions and the stability in incidence over time suggests that OS carcinogenesis is not influenced by environmental or time-varying exposures.
Identifiants
pubmed: 33963769
doi: 10.1002/ijc.33673
pmc: PMC9137041
mid: NIHMS1802112
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1044-1053Subventions
Organisme : NCI NIH HHS
ID : T32 CA099936
Pays : United States
Organisme : NIH HHS
ID : T32 CA099936
Pays : United States
Informations de copyright
© 2021 UICC.
Références
PLoS Med. 2016 Sep 06;13(9):e1002118
pubmed: 27598322
J Pediatr Hematol Oncol. 2005 Jun;27(6):314-8
pubmed: 15956884
Br J Cancer. 2009 Jan 13;100(1):188-93
pubmed: 19127271
J Clin Oncol. 2002 Aug 15;20(16):3484-94
pubmed: 12177110
Cancer Causes Control. 2015 Aug;26(8):1127-39
pubmed: 26054913
Adv Anat Pathol. 2018 Jul;25(4):217-222
pubmed: 29668499
Int J Cancer. 2009 Jul 1;125(1):229-34
pubmed: 19330840
Science. 2015 Jan 2;347(6217):78-81
pubmed: 25554788
Cancer. 2016 Dec 1;122(23):3673-3681
pubmed: 27496084
Cancer. 2018 Sep 15;124(18):3742-3752
pubmed: 30311632
Nat Genet. 2014 Nov;46(11):1173-86
pubmed: 25282103
Int J Cancer. 2018 Nov 15;143(10):2449-2457
pubmed: 30238973
Am J Epidemiol. 1993 Jul 1;138(1):10-28
pubmed: 8333423
Pediatr Blood Cancer. 2013 Jun;60(6):1009-15
pubmed: 23255238
J Natl Cancer Inst. 2009 Apr 15;101(8):581-91
pubmed: 19351917
Bone. 2013 Aug;55(2):347-52
pubmed: 23643679
J Clin Oncol. 2008 Nov 20;26(33):5368-73
pubmed: 18809616
J Bone Miner Res. 2006 Dec;21 Suppl 2:P58-63
pubmed: 17229010
Lancet. 2020 Nov 7;396(10261):1511-1524
pubmed: 33160572
Elife. 2016 Jul 26;5:
pubmed: 27458798
Lancet Oncol. 2017 Jun;18(6):719-731
pubmed: 28410997
Cancer. 2009 Apr 1;115(7):1531-43
pubmed: 19197972
BMJ. 1992 May 2;304(6835):1137-43
pubmed: 1392790
Nat Genet. 2020 Mar;52(3):331-341
pubmed: 32025003
Pediatr Blood Cancer. 2010 Jul 1;54(7):868-9
pubmed: 20232445
Am J Surg Pathol. 1981 Jan;5(1):47-59
pubmed: 6941703
Br J Cancer. 2003 Nov 3;89(9):1638-44
pubmed: 14583762
Cancer Epidemiol. 2019 Dec;63:101596
pubmed: 31520938
Br J Cancer. 2010 Jan 5;102(1):220-6
pubmed: 19935795
Eur J Cancer. 2006 Sep;42(13):2124-35
pubmed: 16919776
J Natl Cancer Inst. 1996 Mar 6;88(5):270-8
pubmed: 8614005
N Engl J Med. 2015 Dec 24;373(26):2499-511
pubmed: 26699166
J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43
pubmed: 17971527
J Natl Cancer Inst. 1995 May 17;87(10):732-41
pubmed: 7563150
Cancer Causes Control. 2011 May;22(5):681-8
pubmed: 21336591
Stat Med. 2009 Dec 20;28(29):3670-82
pubmed: 19856324
J Clin Oncol. 2003 May 15;21(10):2011-8
pubmed: 12743156
JAMA Oncol. 2017 Dec 1;3(12):1640-1645
pubmed: 28772286
Pediatr Blood Cancer. 2004 Jan;42(1):59-63
pubmed: 14752796
Eur J Cancer. 2009 Mar;45(5):747-55
pubmed: 19117750
Int J Cancer. 2015 Nov 1;137(9):2060-71
pubmed: 26135522